bf/NASDAQ:VRDN_icon.jpeg

COM:VIRIDIANTHERAPEUTICS

Viridian Therapeutics

  • Stock

USD

Last Close

19.62

22/11 21:00

Market Cap

783.10M

Beta: -

Volume Today

858.39K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-2.16M
-
-7.89M
265.33%
-11.33M
43.57%
-12.67M
11.88%
-26.51M
109.18%
-32.70M
23.35%
-41.87M
28.04%
-110.72M
164.41%
-79.41M
28.27%
-129.87M
63.54%
-237.73M
83.05%
depreciation and amortization
148.31K
-
144K
2.91%
184K
27.78%
189K
2.72%
308K
62.96%
281K
8.77%
288K
2.49%
239K
17.01%
120K
49.79%
255K
112.50%
522K
104.71%
deferred income tax
177K
-
868K
-
-416K
-
-432K
3.85%
56K
112.96%
1.04M
1,753.57%
12.04M
-
stock based compensation
4.30M
-
3.02M
29.85%
2.11M
29.98%
2.41M
14.12%
3.68M
52.72%
3.97M
7.91%
3.65M
8.19%
14.46M
296.84%
19.77M
36.64%
67.17M
239.85%
change in working capital
-649.45K
-
105K
116.17%
1.10M
946.67%
2.18M
98.54%
-4.47M
304.67%
1.94M
143.42%
1.65M
14.85%
4.43M
168.14%
1.72M
61.06%
15.96M
825.87%
-9.43M
159.05%
accounts receivables
201.59K
-
-271K
234.43%
694K
356.09%
-130K
118.73%
-1.44M
1,004.62%
1.43M
199.72%
-84K
105.87%
99K
217.86%
-451K
555.56%
349K
177.38%
inventory
-187.10K
-
178K
195.14%
-8K
104.49%
123K
1,637.50%
-50.90M
41,482.11%
-57.80M
13.55%
451K
-
-349K
177.38%
accounts payables
-279.73K
-
383K
236.92%
633K
65.27%
2.03M
220.38%
-101K
104.98%
-335K
231.68%
525K
256.72%
-426K
181.14%
1.66M
488.50%
11.52M
596.31%
-12.04M
204.48%
other working capital
-384.20K
-
-185K
51.85%
-220K
18.92%
161K
173.18%
47.97M
29,695.65%
58.64M
22.23%
1.21M
97.94%
4.75M
292.89%
69K
98.55%
4.44M
6,331.88%
2.62M
41.08%
other non cash items
1.49M
-
953K
36.17%
132K
86.15%
93K
29.55%
94K
1.08%
376K
300%
340K
9.57%
72.57M
21,243.82%
7.49M
89.69%
54K
99.28%
-16.75M
31,109.26%
net cash provided by operating activities
-1.17M
-
-2.21M
89.50%
-6.90M
211.70%
-7.23M
4.83%
-28.17M
289.53%
-26.84M
4.70%
-36.06M
34.32%
-29.78M
17.41%
-54.58M
83.29%
-93.84M
71.92%
-184.17M
96.26%
investments in property plant and equipment
-4.77K
-
-266K
5,477.69%
-123K
53.76%
-3K
97.56%
-246K
8,100%
-445K
80.89%
-84K
81.12%
-42K
50%
-338K
704.76%
-797K
135.80%
-898K
12.67%
acquisitions net
1.28M
-
-28.31M
-
29.37M
203.75%
79K
99.73%
114.33M
144,620.25%
purchases of investments
-62.46M
-
-32.69M
47.66%
-81.81M
150.25%
-188.43M
130.34%
-223.26M
18.49%
-407.88M
82.69%
sales maturities of investments
33M
-
61M
84.85%
2M
96.72%
114.40M
5,619.90%
108.94M
4.78%
314.53M
188.73%
other investing activites
10.45K
-
-8K
176.53%
28K
450%
28.31M
-
-3K
100.01%
-114.33M
-
net cash used for investing activites
5.68K
-
-274K
4,919.70%
-95K
65.33%
-3K
96.84%
1.03M
34,566.67%
-29.91M
2,992.36%
28.23M
194.38%
-50.48M
278.85%
-74.29M
47.17%
-115.13M
54.96%
-94.25M
18.13%
debt repayment
-10.52M
-
-42K
99.60%
-76K
80.95%
-84K
10.53%
-4.67M
5,455.95%
-2.33M
-
-10.29M
341.19%
-446K
-
-14.49M
3,147.98%
common stock issued
6.64M
-
13.10M
97.10%
48.56M
-
44.53M
8.31%
2.28M
94.87%
25.10M
999.61%
114.24M
355.07%
291.87M
155.49%
125.07M
57.15%
common stock repurchased
-363K
-
-173K
52.34%
-44K
-
183K
-
580K
216.94%
dividends paid
-285K
-
-44K
-
-14.49M
-
other financing activites
12.07M
-
795K
93.41%
50K
93.71%
8.57M
-
-2.61M
130.48%
120K
104.59%
86.59M
72,056.67%
11.03M
87.26%
30.63M
177.65%
128.99M
321.09%
net cash used provided by financing activities
1.26M
-
7.40M
487.57%
12.71M
71.77%
-257K
102.02%
52.47M
20,516.34%
41.92M
20.11%
70K
99.83%
101.31M
144,630%
125.28M
23.65%
322.24M
157.23%
225.67M
29.97%
effect of forex changes on cash
net change in cash
96.81K
-
4.91M
4,971.58%
5.71M
16.35%
-7.49M
231.12%
25.34M
438.23%
-14.84M
158.55%
-7.76M
47.69%
21.05M
371.28%
-3.60M
117.09%
113.28M
3,248.42%
-52.75M
146.57%
cash at beginning of period
112.53K
-
209K
85.72%
5.12M
2,349.28%
10.83M
111.60%
22.10M
104.06%
47.44M
114.63%
32.61M
31.27%
24.85M
23.80%
45.90M
84.73%
42.30M
7.84%
155.58M
267.81%
cash at end of period
209.35K
-
5.12M
2,345.21%
10.83M
111.60%
3.34M
69.16%
47.44M
1,319.96%
32.61M
31.27%
24.85M
23.80%
45.90M
84.73%
42.30M
7.84%
155.58M
267.81%
102.83M
33.91%
operating cash flow
-1.17M
-
-2.21M
89.50%
-6.90M
211.70%
-7.23M
4.83%
-28.17M
289.53%
-26.84M
4.70%
-36.06M
34.32%
-29.78M
17.41%
-54.58M
83.29%
-93.84M
71.92%
-184.17M
96.26%
capital expenditure
-4.77K
-
-266K
5,477.69%
-123K
53.76%
-3K
97.56%
-246K
8,100%
-445K
80.89%
-84K
81.12%
-42K
50%
-338K
704.76%
-797K
135.80%
-898K
12.67%
free cash flow
-1.17M
-
-2.48M
111.42%
-7.02M
183.22%
-7.23M
3.03%
-28.41M
292.77%
-27.29M
3.96%
-36.14M
32.43%
-29.82M
17.48%
-54.92M
84.16%
-94.64M
72.32%
-185.07M
95.56%

All numbers in USD (except ratios and percentages)